LifeMD falls after cutting FY revenue forecast, Q3 revenue miss
** Shares of telehealth firm LifeMD LFMD.O fall 16.9% to $3.93 in extended trading ** Co reports Q3 revenue of $60.2 million, missing analysts' average estimate of $62.1 million, according to data compiled by LSEG ** LFMD expects 2025 revenue in the range of $192 million to $193 million, compared to the previous projection of $250 million to $255 million ** LFMD stock was down 4.44% YTD (Reporting by Padmanabhan Ananthan) ((Padmanabhan.Ananthan@thomsonreuters.com))
Recent news on LifeMD
See all newsLifeMD Q1 revenue beats estimates on record telehealth subscriber additons
Brief: LifeMD Q1 Adjusted EBITDA USD -4.5 Million Vs. IBES Estimate USD -4.66 Million
LifeMD rises after adding new daily obesity pill to weight management program
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US (updated)
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US